Gene · 409
Papers2,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| β 2-Adrenoceptor Agonists Promote Extracellular Signal-Regulated Kinase 1/2 Dephosphorylation in Human Airway Epithelial Cells by Canonical, cAMP-Driven Signaling Independently of β-Arrestin 2. | Mol Pharmacol | 2021 | 34341099 | PubTator, text mining | PubMed |
| Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. | JHEP Rep | 2021 | 34337369 | PubTator, text mining | PubMed |
| Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking. | Mol Pharmacol | 2021 | 34315812 | PubTator, text mining | PubMed |
| Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4/CREB/KDM6B pathway in an experimental GMH rat model. | J Neuroinflammation | 2021 | 34275493 | PubTator, text mining | PubMed |
| Pharmacological and genetic manipulations at the µ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice. | Neuropsychopharmacology | 2021 | 34257415 | PubTator, text mining | PubMed |
| Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor. | Elife | 2021 | 34254582 | PubTator, text mining | PubMed |
| Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders. | Transl Psychiatry | 2021 | 34226487 | PubTator, text mining | PubMed |
| The disruption of protein-protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition. | Acta Pharm Sin B | 2021 | 34221862 | PubTator, text mining | PubMed |
| The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment. | Acta Pharm Sin B | 2021 | 34221859 | PubTator, text mining | PubMed |
| PRP4 Promotes Skin Cancer by Inhibiting Production of Melanin, Blocking Influx of Extracellular Calcium, and Remodeling Cell Actin Cytoskeleton. | Int J Mol Sci | 2021 | 34209674 | PubTator, text mining | PubMed |
| Molecular Evolution of Phototransduction Pathway Genes in Nocturnal and Diurnal Fireflies (Coleoptera: Lampyridae). | Insects | 2021 | 34207188 | PubTator, text mining | PubMed |
| DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML). | Genes (Basel) | 2021 | 34200630 | PubTator, text mining | PubMed |
| Protective effects of miR-155-5p silencing on IFN-γ-induced apoptosis and inflammation in salivary gland epithelial cells. | Exp Ther Med | 2021 | 34194560 | PubTator, text mining | PubMed |
| Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist. | ACS Pharmacol Transl Sci | 2021 | 34151207 | PubTator, text mining | PubMed |
| Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1. | Biochem Pharmacol | 2021 | 34129856 | PubTator, text mining | PubMed |
| miRNAs through β-ARR2/p-ERK1/2 pathway regulate the VSMC proliferation and migration. | Life Sci | 2021 | 34111458 | PubTator, text mining | PubMed |
| Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. | Alzheimers Res Ther | 2021 | 34108016 | PubTator, text mining | PubMed |
| β-Arrestin-1 is required for adaptive β-cell mass expansion during obesity. | Nat Commun | 2021 | 34099679 | PubTator, text mining | PubMed |
| CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms. | Nucleic Acids Res | 2021 | 34086943 | PubTator, text mining | PubMed |
| NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors. | Methods Mol Biol | 2021 | 34085273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/409/papers?page=27